Sex Cerebral Vasoreactivity Differences in Parkinson’s Disease: Uncovering the Tip of the Iceberg
Objective: To determine sex differences in cerebral vasoreactivity (cVR) in patients with Parkinson’s disease (PD) and its association with the clinical spectrum of the disease.…Is GPI DBS as effective to STN DBS for tremor control in Parkinson’s disease?
Objective: To compare the benefits of GPI and STN DBS on tremor in Parkinson’s disease (PD). Background: DBS is a highly effective surgical therapy for…Do differences in risk aversion and perceived social support contribute to gender disparities in deep brain stimulation utilization in Parkinson’s disease
Objective: To examine gender differences in risk tolerance in Parkinson’s disease and to determine factors associated with risk tolerance. Background: Deep brain stimulation (DBS) is…Viability and Accuracy of Visual Estimation in Determining Directional Deep Brain Stimulation Lead Orientation
Objective: To assess the viability and accuracy of visual estimation in determining directional deep brain stimulation (DBS) lead orientation. Background: Directional DBS leads show large…The Current State of Wearable Device Use in Parkinson’s Disease (A Survey of Individuals with Parkinson’s and Specialist Clinicians)
Objective: To develop a better understanding of the current use of consumer and medical wearable monitoring devices in the clinical management of PD and to…Wearable Device for Real-Time Prevention of Freezing-of-Gait in Parkinson’s Disease
Objective: In our previous work, we developed machine learning models to predict and detect freezing-of-gait (FOG) [1]. In this study, we aimed to use those…SMaRT-PD: A Clinical Decision Support System for the Management of Parkinson’s Disease
Objective: To optimise the accuracy of a clinical decision support system (CDSS) to support Self-Management, Remote monitoring and Timely review in Parkinson’s Disease (SMaRT-PD). Background:…Speech Processing System for Parkinson’s Disease Using Mixed Reality
Objective: Our initiative aims to develop an integrated AR/MR platform for collecting diagnostic data and monitoring patients with neurodegenerative diseases using digital markers from registered…Transcriptome analysis of proteasome and inflammation in the substantia nigra of Parkinson’s disease patients: the GEO database.
Objective: In this study, we analyzed transcriptome data regarding protein degradation pathways and inflammation sourced from GEO database. Background: Parkinson's disease (PD) is the second…Remote DNA Collection for Parkinson’s Research: Insights from AccessPD
Objective: Established in 2022, the AccessPD registry aims to create a comprehensive database of electronic health records, self-reported outcomes, and genetic data from Parkinson's disease…
- « Previous Page
- 1
- …
- 294
- 295
- 296
- 297
- 298
- …
- 553
- Next Page »